Suchergebnisse - "Usmani, Saad Z"

PubPharm (23)

1

Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level Data

enthalten in: Advances in therapy | 2024

von Durie, B. | Kumar, S. | Ammann, E. | +5

2

Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level Data

enthalten in: Advances in therapy | 2024

von Durie, B. | Kumar, S. | Ammann, E. | +5

3

Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma : Findings from the MASTER and GRIFFIN Trials

enthalten in: Transplantation and cellular therapy | 2023

von Chhabra, S. | Callander, N. | Watts, N. | +34

4

Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma : subgroup analyses of the noninferiority, phase 3 COLUMBA study

enthalten in: Annals of hematology | 2021

von Iida, S. | Ishikawa, T. | Min, C. | +12

5

Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma : COLUMBA clinical trial results

enthalten in: Journal of cancer research and clinical oncology | 2021

von Usmani, S. | Mateos, M. | Hungria, V. | +16

6

Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study

enthalten in: Annals of hematology | 2021

von Iida, S. | Ishikawa, T. | Min, C. | +12

7

Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study

enthalten in: Annals of hematology | 2021

von Iida, S. | Ishikawa, T. | Min, C. | +12

8

Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study

enthalten in: Annals of hematology | 2021

von Iida, S. | Ishikawa, T. | Min, C. | +12

9

Daratumumab subcutaneous formulation for the treatment of multiple myeloma

enthalten in: Expert opinion on biological therapy | 2020

von Paul, B. | Hamadeh, I. | Atrash, S. | +3

10

Evaluation of Montelukast for the Prevention of Infusion-related Reactions With Daratumumab

enthalten in: Clinical lymphoma, myeloma & leukemia | 2020

von Moore, D. | Arnall, J. | Thompson, D. | +8